pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,159 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: patent expiry×type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT06572046: STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies

Sponsor: IRCCS Fondazione Stella Maris. Phase: . Conditions: Hereditary Spastic Paraplegia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07368946: Phosphate Assessment in Chronic Kidney Disease Patients Study

Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease Mineral and Bone Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07343427: Impact of GON PRF on Central Sensitization in Migraine Patients

Sponsor: Ankara City Hospital Bilkent. Phase: NA. Conditions: Migraine, Central Sensitization

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06150027: Efficacy of a Systematic Referral to Palliative Care of Patients Who Need for Palliative Care During an Unscheduled Visit in Comprehensive Anticancer Centers

Sponsor: Centre Leon Berard. Phase: NA. Conditions: Cancer, Emergencies

full page →ctgov ↗
›RECRUITINGphase readoutNCT05043870: Combined Immunosuppression for Pediatric Crohn's Disease

Sponsor: Children's Hospital of Fudan University. Phase: PHASE4. Conditions: Crohn Disease, Infliximab, Immunosuppression, Children, Only

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07573670: A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia

Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Newly Diagnosed Mixed Phenotype Acute Leukemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07607470: Large Algorithm Setting and Validation Study

Sponsor: Nanopath, Inc. Phase: . Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, Vaginitis, Vaginal Diseases, Genital Diseases, Female, Female Urogenital Diseases, Urogenital Disease, Candidiasis, Mycoses, Vulvovaginitis, Vulvar Diseases, Vaginosis, Bacterial

full page →ctgov ↗
›RECRUITINGphase readoutNCT07030673: Early Discontinuation of Antibiotic Therapy in Elderly Patients Hospitalized for a Viral Infection

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Elderly, Antibiotics Overuse, Viral Infections, PCR Multiplex

full page →ctgov ↗
›COMPLETEDphase readoutNCT04232969: Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease

Sponsor: University College, London. Phase: PHASE3. Conditions: Parkinson's Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT06748469: Efficacy of Pulse Radiofrequency Durations in Lumbosacral Pain

Sponsor: Ankara City Hospital Bilkent. Phase: . Conditions: RADICULAR PAIN

full page →ctgov ↗
›RECRUITINGphase readoutNCT07367269: Effect of Mandala Coloring on Anxiety, Distress, and Comfort in Breast Cancer Patients Receiving Outpatient Chemotherapy

Sponsor: Artvin Coruh University. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07209683: The Effect of Near-infrared Light Therapy on Brain Function and Cognition in Young and Older Adults

Sponsor: University of Oklahoma. Phase: NA. Conditions: Cognition, Neurovascular Coupling Mechanism and Cognitive Function, Neurovascular Control, Brain Aging, Brain Activity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07578454: VRehab-SMA Phase 1.2

Sponsor: University of Oxford. Phase: NA. Conditions: Spinal Muscular Atrophy (SMA)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05338905: Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial

Sponsor: Roswell Park Cancer Institute. Phase: NA. Conditions: Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02313194: Spinal Cord Neuromodulation for Spinal Cord Injury

Sponsor: University of California, Los Angeles. Phase: PHASE1. Conditions: Cervical Spinal Cord Injury, Tetraparesis, Tetraplegia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07323056: Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung Cancer

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China. Phase: PHASE2. Conditions: EGFR-mutant Non-small Cell Lung Cancer, Potentially Resectable

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04703322: A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

Sponsor: Daiichi Sankyo Co., Ltd.. Phase: PHASE2. Conditions: Tenosynovial Giant Cell Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT07597122: MIRNA QUANTIFICATION IN PATIENTS WITH SEPTIC SHOCK

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: . Conditions: Sepsis and Septic Shock

full page →ctgov ↗
›COMPLETEDphase readoutNCT06731322: Gut, Inflammation and Nutrition in Adult Patients After Fontan Operation

Sponsor: University Medical Centre Ljubljana. Phase: . Conditions: Fontan Circulation, Fontan Procedure

full page →ctgov ↗
›RECRUITINGphase readoutNCT04188522: Imaging Post-Stroke Recovery: Using MEG to Evaluate Cognition

Sponsor: Johns Hopkins University. Phase: . Conditions: Stroke, Stroke Sequelae, Stroke/Brain Attack

full page →ctgov ↗
›COMPLETEDphase readoutNCT06893731: Healthcare Utilization and Costs Among Hospitalized Patients With Cardiomyopathy

Sponsor: China National Center for Cardiovascular Diseases. Phase: . Conditions: Cardiomyopathies, Cost

full page →ctgov ↗
›COMPLETEDphase readoutNCT04474431: Correlation of VEGF-A and Fluid Balance in Septic Shock

Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Septic Shock

full page →ctgov ↗
›COMPLETEDphase readoutNCT06677931: Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Melasma

Sponsor: Fujian Medical University Union Hospital. Phase: NA. Conditions: Melasma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06789731: Mindfulness-Based Interventions Targeting First-Generation College Student Retention in Rural Environments

Sponsor: University of South Dakota. Phase: NA. Conditions: Depression, Anxiety

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03428802: Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

Sponsor: Rutgers, The State University of New Jersey. Phase: PHASE2. Conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Neoplasm, Metastatic Malignant Solid Neoplasm, POLD1 Gene Mutation, POLE Gene Mutation, Recurrent Malignant Solid Neoplasm, Recurrent Ovarian Carcinoma, Stage III Breast Cancer AJCC v7, Stage III Ovarian Cancer AJCC v8, Stage IIIA Breast Cancer AJCC v7, Stage IIIA Ovarian Cancer AJCC v8, Stage IIIB Breast Cancer AJCC v7, Stage IIIB Ovarian Cancer AJCC v8, Stage IIIC Breast Cancer AJCC v7, Stage IIIC Ovarian Cancer AJCC v8, Stage IV Breast Cancer AJCC v6 and v7, Stage IV Ovarian Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03811002: Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06308653: Psilocybin for Major Depressive Disorder (MDD)

Sponsor: Usona Institute. Phase: PHASE3. Conditions: Depressive Disorder, Major

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07217353: The Use of a Novel Vaginal Speculum for Endometrial Biopsies

Sponsor: Rocky Vista University, LLC. Phase: NA. Conditions: Endometrial Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07366645: Clinical and Cost-Effectiveness of Silver Diamine Fluoride and Silver Fluoride, With or Without Application of LED, in Arresting Incipient Permament Molar Caries

Sponsor: Cairo University. Phase: NA. Conditions: Incipient Caries

full page →ctgov ↗
›RECRUITINGphase readoutNCT05523245: Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: . Conditions: Rectal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07625072: Mental Rehearsal in Emergency Cricothyroidotomy Training

Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Difficult Airway, Medical Training, Airway Management, Cricothyroidotomy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06060977: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

Sponsor: Inmagene LLC. Phase: PHASE1. Conditions: Alopecia Areata (AA)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04027777: Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation

Sponsor: Aktiia SA. Phase: NA. Conditions: Blood Pressure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07299877: Perineural Dexamethasone, Dexmedetomidine, or Their Combination to Reduces Rebound Pain After Supraclavicular Brachial Plexus Block

Sponsor: Al-Azhar University. Phase: PHASE4. Conditions: Brachial Plexus Blocks

full page →ctgov ↗
›RECRUITINGphase readoutNCT06138275: Elranatamab in R/R Multiple Myeloma

Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07487857: Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy

Sponsor: University of Castilla-La Mancha. Phase: NA. Conditions: Cerebral Palsy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07633457: Comparison Between Outcomes of Closure of Idiopathic Macular Hole Using Autologus Tenon Capsule Graft and Internal Limiting Membrane Flap Techniques (Pilot Study)

Sponsor: Ain Shams University. Phase: NA. Conditions: Macular Hole Surgery, ILM Peeling, Tenon Capsule, ILM Flap, Macular Hole

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05753501: Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Sponsor: AbbVie. Phase: PHASE1. Conditions: Hematologic Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07372157: Neuromuscular Balance Exercise Effects in Overweight and Obese Individuals

Sponsor: Marmara University. Phase: NA. Conditions: Overweight and Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06245057: Enriched Holistic Care to Eradicate Disparities in Maternal Morbidity

Sponsor: University of Pennsylvania. Phase: NA. Conditions: Morbidity;Perinatal

full page →ctgov ↗
›COMPLETEDphase readoutNCT07084857: Association Between Isokinetic Lower Extremity Muscle Strength and Bone Mineral Density in Elderly Women With and Without Osteoporosis

Sponsor: Cairo University. Phase: . Conditions: Osteoporosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06497101: Effectiveness Trial of Temperament Based Therapy With Support (TBT-S)

Sponsor: Oslo University Hospital. Phase: NA. Conditions: Anorexia Nervosa

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07556601: Ultra-rapid Blastocyst Vitrification: Pilot Randomized Study

Sponsor: Fundacion Dexeus. Phase: NA. Conditions: Infertility

full page →ctgov ↗
›RECRUITINGphase readoutNCT04799301: Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: PHASE1. Conditions: Diet Therapy, Healthy Volunteers

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07541001: PRL3-Zumab in Patients With Advanced Solid Tumors

Sponsor: Intra-IMMUSG Pte Ltd. Phase: PHASE2. Conditions: Advanced Malignant Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT07606001: Yellow Potatoes and Carotenoids

Sponsor: University of Florida. Phase: NA. Conditions: Carotenoids

full page →ctgov ↗
›RECRUITINGphase readoutNCT04431479: Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

Sponsor: Fred Hutchinson Cancer Center. Phase: . Conditions: Chronic Graft Versus Host Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06871579: Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: NA. Conditions: Helicobacter Pylori

full page →ctgov ↗
›RECRUITINGphase readoutNCT07530588: Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis

Sponsor: University Hospital of North Norway. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›COMPLETEDphase readoutNCT04838288: Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™

Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Renal Transplant

full page →ctgov ↗
← prev
page 64 of 104
next →